INBIOGEN Co., Ltd. (KRX:101140)
12,640
+170 (1.36%)
At close: Sep 4, 2025
INBIOGEN Market Cap
INBIOGEN has a market cap or net worth of 125.21 billion as of September 8, 2025. Its market cap has increased by 174.33% in one year.
Market Cap
125.21B
Enterprise Value
123.25B
Revenue
7.74B
Ranking
n/a
PE Ratio
8.33
Stock Price
12,640.00
Market Cap Chart
Since August 14, 2008, INBIOGEN's market cap has decreased from 218.39B to 125.21B, a decrease of -42.67%. That is a compound annual growth rate of -3.20%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Sep 9, 2025 | 125.21B | 142.67% |
Dec 29, 2022 | 51.60B | -72.31% |
Dec 30, 2021 | 186.34B | -26.46% |
Dec 30, 2020 | 253.36B | 119.86% |
Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Hyundai Motor Company | 47.75T |
Kia Corporation | 40.72T |
Hyundai Mobis Co.,Ltd | 28.84T |
Hanjin Kal | 7,354.62B |
COWAY | 7,319.10B |
Hankook Tire & Technology | 4,806.36B |
Kangwon Land | 3,561.21B |
F&F Co., Ltd | 2,596.62B |